Cleared Traditional

K931133 - CLINICAL INFOR SYST(CIS) W/FETAL MONIT REMOTE DISP

K931133 is an FDA 510(k) clearance for CLINICAL INFOR SYST(CIS) W/FETAL MONIT ..., manufactured by Clinicomp, Inc.. The device is a Class 2 Obstetrics & Gynecology device with product code HGM cleared through the Traditional 510(k) pathway after a 754-day FDA review.

K931133 · Clinicomp, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
754d
Days
Class 2
Risk

K931133 is an FDA 510(k) clearance for the CLINICAL INFOR SYST(CIS) W/FETAL MONIT REMOTE DISP. Classified as System, Monitoring, Perinatal (product code HGM), Class II - Special Controls.

Submitted by Clinicomp, Inc. (San Diego, US). The FDA issued a Cleared decision on March 29, 1995 after a review of 754 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.2740 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Clinicomp, Inc. devices

FDA 510(k) Submission Details - K931133

510(k) Number K931133 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 1993
Decision Date March 29, 1995
Days to Decision 754 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
594d slower than avg
Panel avg: 160d · This submission: 754d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HGM Device Classification - Class 2, Special Controls

Product Code HGM System, Monitoring, Perinatal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.2740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - HGM System, Monitoring, Perinatal

All 160
Devices cleared under the same product code (HGM) and FDA review panel - the closest regulatory comparables to K931133.
SERIES 50XM
K954351 · Hewlett-Packard GmbH · Mar 1996
COROMETRICS FETAL MOVEMENT DETECTION KIT
K955559 · Ge Medical Systems Information Technologies · Mar 1996
FETALGARD 3000 - MODELS IP1, IP2, AP2 AND AP3
K950420 · Analogic Corp. · May 1995
R & D BATTERIES, INC. PART NUMBERS 5235, 5506 & 5050
K935301 · R & D Batteries, Inc. · Dec 1994
R AND D BATTERIES
K935377 · R & D Batteries, Inc. · Dec 1994
MODEL 118 FETAL/MATERNAL MONITOR
K934959 · Ge Medical Systems Information Technologies · Aug 1994